Tag: DECLARE-TIMI 58 trial

Latest articles

Entries for the Pf Awards 2022 are officially open

Enter today! The Pf Awards 2022 are officially open

New Year | New Suite of Categories | New Candidates Would you like to be recognised as a top performer in the UK Pharmaceutical industry? Enter...
MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence for Ryeqo▼ (relugolix combination therapy), for the treatment of moderate to severe...
NICE issues draft guidance on dependence-forming medicines

NICE issues draft guidance on dependence-forming medicines  

The National Institute for Health and Care Excellence (NICE) has issued a new draft guideline on shared decision-making which looks at safe prescribing and...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
pharmafield logo - pharma news

A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT

What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence for Ryeqo▼ (relugolix combination therapy), for the treatment of moderate to severe...
Ground-breaking AI test could transform breast cancer diagnosis and treatment

Ground-breaking AI test could transform breast cancer diagnosis and treatment

Panakeia’s PANProfiler Breast assay - the world’s first AI software that can predict biomarker status from digitally imaged routine pathology samples - has received...
NICE issues draft guidance on dependence-forming medicines

NICE issues draft guidance on dependence-forming medicines  

The National Institute for Health and Care Excellence (NICE) has issued a new draft guideline on shared decision-making which looks at safe prescribing and...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription